The EU Commission caused quite a stir in August 2012, when it announced the harmonization of the EN ISO 14971:2012 risk-management standard for the medical device industry with absolutely no ...
Overview: FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in many companies. One major failing is lack of sufficient or targeted risk-based company-wide V&V ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback